Adjuvant Treatment With a Mammalian Target of Rapamycin Inhibitor, Sirolimus, and Steroids Improves Outcomes in Patients With Severe H1N1 Pneumonia and Acute Respiratory Failure*-Reference-Cited by-同舟云学术

Adjuvant Treatment With a Mammalian Target of Rapamycin Inhibitor, Sirolimus, and Steroids Improves Outcomes in Patients With Severe H1N1 Pneumonia and Acute Respiratory Failure*

Published:2014-02 Issue:2 Volume:42 Page:313-321
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Wang Chun-Hua,Chung Fu-Tsai,Lin Shu-Min,Huang Shu-Yi,Chou Chun-Liang,Lee Kang-Yun,Lin Tzou-Yien,Kuo Han-Pin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference58 articles.

1. Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza

2. Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans

3. Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings

4. Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets

5. Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of sirolimus in hospitalised patients with COVID-19 pneumonia;Respiratory Investigation;2024-03

2. Respiratorische Virusinfektionen;Medizinische Klinik - Intensivmedizin und Notfallmedizin;2023-08-29

3. Senotherapeutics: An emerging approach to the treatment of viral infectious diseases in the elderly;Frontiers in Cellular and Infection Microbiology;2023-03-29

4. Risk Factors for Influenza-Induced Exacerbations and Mortality in Non-Cystic Fibrosis Bronchiectasis;Viruses;2023-02-14

5. Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus;Molecular Biology Reports;2023-01-25